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When exposures to sparsely ionising radiation such as X- or
y-rays are protracted in time, generally the risk of radiation-
induced cancer decreases. Qualitatively, a similar result has
been observed for neoplastic transformation when the
exposure of cells in vitro was protracted (Han et al., 1980;
Hill et al., 1984a, 1987). However, during the course of our
studies in vitro with a densely ionising radiation, unexpected
results were obtained: dose protraction led to enhanced
transformation. To explain these results a cell-based model
was developed (Elkind, 1991, 1992, 1994); a model that also
explains enhanced tumorigenesis when doses of high- linear
energy transfer (LET) radiation are protracted in time, as in
the instance of the inverse relationship between lung cancer
risk among uranium miners and radon concentration (e.g.
Lubin et al., 1994). The formal properties of this model lead
to the inference that, under certain circumstances, the
protraction of doses of X- or y-rays could also increase
rather than decrease the risk of cancer. In this editorial the
radiobiology of the model and its supporting data are
described as a basis for applying the model to the question
of the increasing incidence of breast cancer.
Neoplastic transformation in vitro
In the 1970s several groups initiated studies of radiation-
induced neoplastic transformation in vitro. The end point that
was used was focus formation of C3H mouse embryo lOT1/2,
Balb/c 3T3 or Swiss 3T3 fibroblasts. These cells express post-
confluence inhibition of cell division. Effective cell-to-cell
communication results in the down-regulation of growth but
not in transformed cells. Thus, densely staining discrete foci
ofpiled-up cells, which had grown in the midst of a confluent
layer of normal cells, were readily identified and scored.
Because of a long-term interest in the role of repair processes
in radiation-induced changes in mammalian cells, early in our
work with IOT1/2 cells at the US Argonne National
Laboratory we examined the role of repair of sublethal
damage as well as damage subeffective in neoplastic
transformation. With X- and y-rays, i.e. low linear energy
transfer (low-LET) radiations, the effect of repair was
examined by applying dose fractionation and/or the
protraction of exposures in time via continuous, low dose-
rate irradiation. Qualitatively, our results were consistent
with tumour induction in animals. Even though sublethal
damage (Elkind and Sutton, 1959) was effectively repaired in
lOT1/2 cells (Han and Elkind, 1979), the concomitant repair
of subeffective transformation damage resulted in a net
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reduction in the frequency of transformed cells (Han et al.,
1980; Hill et al., 1984a, 1987). From this we inferred that in
vivo the repair of sublethal damage - which by itself should
increase tumorigenesis because it would lead to the survival
of more tumour-susceptible cells - was outweighed by the
repair of subeffective tumorigenic damage in order for a
reduction in the frequency of tumours to result (e.g. Upton et
al., 1970).
In addition to protracted exposures of low-LET radiations
to study further the role of repair a high-LET radiation was
used. From numerous studies radiobiologists have deter-
mined that with increasing LET (increasing linear density of
the ionisation) modifiers of radiation effects become less
effective; for example sensitisation by dissolved oxygen,
protection by SH-containing compounds, or damage
enhancement owing to the incorporation of halogenated
pyrimidines into DNA. This loss of effectiveness with LET
also applies to the reductions, due to intracellular repair,
connected with the expression of various end points. For the
latter reason, the influence on transformation and survival of
dose protraction was examined using as a source ofhigh-LET
radiation the beam of fission-spectrum neutrons produced by
the JANUS reactor at the Argonne National Laboratory. We
had expected a result reflecting a lack of repair; that is little
or no change in the yield of transformants and surviving
cells. Instead, we observed an enhancement in transformation
frequency with little change in survival. This unexpected
result led to the development of the ideas that are the subject
of this editorial.
Neoplastic transformation with neutrons
We first reported in 1982 the anomalous enhancement of the
rate of transformation of lOT1/2 cells when doses of fission
neutrons were protracted in time (Hill et al., 1982). Contrary
to what had been observed for other end points such as cell
killing the exposure of cells to fission neutrons at low dose
rate (Hill et al., 1982, 1984b), or to multiple-dose fractions at
a high dose rate (Hill et al., 1985), resulted in an appreciable
enhancement in the yield of transformants. As sketched in
Figure 1, for doses larger than about 10 cGy the low dose-
rate curve was concave downward and became coincident
with the high dose-rate curve at 150-200 cGy. This low-dose
enhancement was confirmed by others: with neutrons of
discrete energies and IOT1/2 cells (Miller et al., 1988), with
reactor neutrons and primary cultures of Syrian hamster
embryo cells (Jones et al., 1989) and with reactor neutrons
and a human hybrid cell, HeLa x normal human fibroblasts
(Redpath et al., 1990). Thus, enhancement was obtained with
immortal rodent cells, lOT1/2, with primary and mortal
Syrian hamster embryo cells and with human cells all without
concomitant enhancement effects on survival.Protracted exposure to X- or y-rays and breast cancer
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Figure 1 The relative positions of the transformation induction
curves at low and high dose rates and the frequencies induced by
five high dose rate dose fractions each separated by 24h (0).
(Based on data contained in Hill et al., 1984b, 1985.) Note that
the two curves converge for high doses and that the first three
multiple dose points follow the low dose rate curve and that the
last two approach the high dose rate curve.
The model, kinetics without repair
In 1990 a biophysical model was described to explain the
enhanced transformation rate when 1OT1/2 cells were
exposed to protracted neutron doses (Elkind, 1991). The
model invoked a sensitive window for transformation in the
cell cycle, that is cells in or around mitosis. Subsequently, the
existence of this window was demonstrated experimentally
(Cao et al., 1992, 1993). Some years earlier, Rossi and
Kellerer (1986) had proposed an explanation of our results
(e.g. Figure 1; Hill et al., 1984b, 1985) based on the
assumption that a transformation-sensitive window existed,
although its location in the cycle was not specified. A
departure similar to that of Rossi and Kellerer was adopted
by Brenner and Hall (1990). Rossi and Kellerer proposed
that in the initial dose range, 0- 10 cGy, the nuclei of 1OT1/2
cells became saturated with damage by multiple traversals of
high-LET particles. They proposed that enhancement resulted
from the transit of cells through a sensitive window during a
protracted exposure, thus reducing the degree of saturation
and increasing the net frequency of transformation. We noted
(Elkind and Hill, 1986) that the Rossi-Kellerer proposal did
not explain results obtained with multiple, high dose rate
dose fractions (Hill et al., 1985). Subsequently, the sensitive
window was shown to be late G2/M phase, also the most
sensitive to killing (Cao et al., 1992, 1993), but insensitive to
promotion by the phorbol ester TPA (Wells et al., 1993).
The essential radiobiological features of the model follow
(Elkind, 1991, 1992, 1993):
* G2/M phase cells constitute an ageinterval sensitive to the
induction of neoplastic transformation by small doses of
ionising radiation. Small doses are specified because cells
in this window also are maximally sensitive to killing.
* In an asynchronous population, cells in the sensitive
window make only a minor contribution to the yield of
transformants by mid-to-large doses (1) because they
comprise only a small fraction of the population, (2)
they are preferentially killed with increasing dose.
* Low doses, at low dose rate of a high-LET radiation,
result in enhanced yields of transformants because (1)
more cells have an opportunity to be exposed in the
window, (2) killing and/or blocks to progression cause
only a minor reduction in the proportion of viable
potentially transformed cells in the window, (3) the
damage per cell is minimised owing to the progression of
cells through the window during exposure, (4) repair has a
minimal effect, if any, in reducing the transformation
signal.
* Large doses at low dose rate of high-LET radiation,
prevent cells from entering the window because of
radiation-induced blocks to progression; similarly, after
multiple fractions of high dose rate radiation. With
increasing dose, these blocks plus the enhanced killing of
sensitive cells cause the yield of transformants to converge
on that due to brief, single exposures (as in Figure 1).
* Dependence on radiation quality: high-LET radiation-
enhanced yield of transformation is observed with low,
protracted doses; in the absence of repair, growth kinetics
dominates.
Low-LET radiation - repair-competent cells, repair
dominates; reduced yields are generally observed. In
repair-deficient cells, if the deficiency in repair is large
enough, kinetics could dominate; thus, the net effect of
protracted X- and y-ray radiation is similar to that of
protracted high-LET radiation with the result that the
yield of transformants would vary inversely with exposure
rate.
Cell-to-cell communication and the sensitive window
Because the enhancement of transformation depends on cells
in a window constituting a small age interval in the cycle, the
persistence of this cohort under various conditions of growth
was examined. In a given instance, because the sensitive
cohort might be only a few per cent of the population, large
reductions in the proportion of such cells could lead to only
small fluctuations in total number. Hence, the loss of the
moiety responsible for transformation enhancement could go
undetected. In Figure 2, two extreme cell cycle distributions
are shown. Ideally, the age density distribution of
asynchronous cells would include cells of all ages, exponen-
tially decreasing in age density from the beginning of GI to
the end of mitosis as sketched. In the instance of the full
contact inhibition ofgrowth at confluence, cells would be in a
narrow age interval designated Go. Relative to the model, one
would expect an enhancement for a distribution of
asynchronous cells, but none for confluent growth-arrested
cells. With the preceding prediction of the model in mind we
examined the residence of lOT1/2 cells in late G2/M phase as
a population undergoes the transition between these growth
states. Using the mitotic index as an indicator of the
proportion of cells in late G2/M phase measurements were
made of its dependence on the starting area density of cells
and the time of growth. For populations whose total number
appeared to increased exponentially and at the same rate
large differences in the mitotic index were observed. The
mitotic index was high, one to a few per cent, as long as
growing cells were infrequently touching, but was lower by
factors of 10 or more when cell-to-cell contact was frequent.
This was true even when the population was only 25-50%
confluent. Also, a progressive decrease in mitotic index was
followed by a progressive decrease of cells in S-phase. These
changes indicated that the transition between the growth
states in Figure 2 starts at the right with a loss of cells from
late G2/M phase, is followed by the depletion of cells in the
age intervals early G2 and S-phases, and result in an
accumulation of cells in G1 as they become down-regulated
and then enter Go.
The preceding population dynamics apply to non-
transformed cells, such as communicating IOTI/2 cells, and
make clear why, when communication becomes general,
transformation enhancement can be lost (Miller et al., 1993).
The negative results with neutrons of Balcer-Kubiczek et al.
(1994) and Saran et al. (1991, 1994) could have been due to
It,kthis effect in view of the likely area densities of their cells. A
similar consideration applies to the lack of an enhancement
reported by Hieber et al. (1987) with a-particles from 2"4Am.
In the latter instance, however, the change in geometry of
1OT1/2 cells from thin, flat, interphase cells to developing
spheres in late G2/mitosis also could have contributed to a
lack ofenhancement because the limited residual range of the
a-particles that were used might not have fully traversed the
sphere-like cells. The preceding transitions in growth state,
which can explain a lack of transformation enhancement, are
unable to account for a window of transformation sensitivity
in mid-G, as proposed by Miller et al. (1995), although
evidently not clearly confirmed by Bettega et al. (1995).
Owing to cell-to-cell contact, mid-GI cells would have
accumulated with population growth in the work of Balcer-
Kubiczek et al. (1994), Saran et al. (1991, 1994) and Hieber et
al. (1987). As a consequence, ifmid-GI was a hotspot the last
authors should have observed enhancements in transforma-
tion.
Cell proliferation and enhancement ratios
In reference to Figure 2, it was noted that the moiety in the
sensitive window is lost as non-transformed cells commu-
nicate; the composition of the population shifts from
proliferation to quiescence. In vivo, the parenchymal cells of
various tissues normally may be essentially quiescent. A
fraction of cells in a normal tissue may be induced to enter
the proliferative cycle to maintain homeostasis in response to
various stimuli such as chronic or acute tissue injury. In such
instances the proliferative status of the population might be
suitably described by a mixture of the growth states in Figure
2. As shown in Figure 3, upon stimulation a transition would
start that now would be in the direction from Go toward
asynchronous growth. With decreasing dose rate ofhigh-LET
Go G1 S G2 M
Cell cycle age (A)
Figure 2 Two extreme growth states of IOT1/2 cells. The age
density distribution, dN/dA, through the cycle would approach
exponential for actively growing asynchronous cells, and a
confluent single-cell layer would approach a narrow interval of
quiescence, Go.
:
Go G1 S G2 M
Cell cycle age (A)
Figure 3 Distribution of cells that are stimulated by intra- or
extracellular signals to emerge from quiescence, Go, and to enter
the proliferation cycle. The sensitive window is only partly
occupied.
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radiation the dependence of transformation yield would
depend on the number of cells in the sensitive window
during the exposure. In a particular tissue, if the sensitive
window does not become populated, an enhancement would
not be observed. A lack of enhancement would also occur if
the LET, dose, and dose rate are such that: (1) the survival of
target cells in the window is reduced enough to nullify the
enhancement that the window's sensitivity could confer; and/
or (2) target cells are prevented from reaching the window in
adequate numbers because of blocks to progression owing to
the radiation itself (or from other causes).
Dose rate dependencies
In radiation biology end points whose magnitude for a given
dose depend on dose rate generally involve the registration of
multiple damaging events. When the radiation is sparsely
ionising, as is the case for X- and y-rays, even quite small
doses require multiple absorption events in, say, the nucleus
of a cell. And generally, as already noted, the magnitude of
the effect is reduced because of repair processes if the dose is
protracted in time. Between the absorption of damaging
events, a repair-competent cell is able to reduce the
effectiveness with which early events can interact with later
events.
In the case of a high-LET radiation, such as fission
neutrons or ac-particles, the rates of energy deposition per
ionising particle are relatively large so that only one or few
traversals in the same cell or nucleus may be required for a
small dose. The question arises: does the enhancement of
neoplastic transformation with protracted exposures of a
high-LET radiation involve the modification of the effective-
ness of energy absorption events received early vs late during
a given exposure? This question is relevant for radiations and
doses for which, in high probability, even single traversals
would suffice for delivery. But the question applies also to
types of radiations and doses which would require multiple
traversals, because the damage due to high-LET radiation is
influenced to only a minor extent by repair processes.
In the model, for a given low dose of a high-LET
radiation a ratio of transformation yields greater than one is
due to kinetics; that is the ability of more cells to be present
in the late G2/M phase during an extended exposure, in the
absence of blocks to cell progression, and the damage is not
repaired. The interaction between multiple absorption events
is not required because the dose rate dependence does not
require intracellular modification of damage. Hence, an
enhanced effect could be observed even if the transformation
is the result of a single nuclear traversal. In the latter event
and for cells normally out of cycle, an enhanced effect would
result only if a stimulus to cycle is present or is developed
during the extended exposure. In a given case, the cytokinetic
stimulus might be independent of the radiation exposure. For
example, in the instance of lung cancer risks from radon
inhalation, tobacco smoking, the breathing of noxious fumes
or the inhalation of dust particles all could and may serve to
stimulate susceptible cells to proliferate owing to the
elaboration of growth factors or compensatory repopulation
resulting from tissue injury. Environmental factors such as
these may have contributed to proliferation in the instance of
uranium and other hard-rock miners who worked in
atmospheres containing high levels of radon (Elkind, 1994).
Generally, lung cancer risks among these miners have been
found to vary inversely with ambient radon concentration
(Darby and Samet, 1994; Lubin et al., 1994).
A stimulus to cause susceptible cells to cycle may also
come from the radiation exposure itself. In the instance of
mice exposed to whole body doses of reactor neutrons, in
specific tissues enhanced tumorigenesis was observed when 24
or 60 weekly exposures were used (Grahn et al., 1992). In a
separate study multiple neutron dose fractions delivered only
over a 1 week period were not accompanied by an
enhancement (Di Majo et al., 1994). The lack of an effect
in the latter compared with the former study is under-Protracted exposure to X- or y-rays and breast cancer
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standable because the time between dose fractions and the
overall time available, 1 week, probably were insufficient for
the generation of the cytokines of tumour-susceptible cells
and the subsequent progression of these cells into the
sensitive window. Another example is the study of rats
breathing radon at different concentrations (Cross, 1992). In
this case, the doses were large enough to have involved
multiple a-particle traversals of the nuclei of target cells. Still,
the clear enhancement of lung cancers that were observed, at
a low vs a high dose rate, could have been due to tissue injury
and the homeostatic controls that caused the proliferation of
target cells rather than the interaction of radiation damage in
those nuclei that received multiple traversals at the low dose
rate.
Enhanced tumorigenesis by X- and y-rays
The few examples cited illustrate the applicability of the
model in explaining the anomalous observation of enhanced
cancer risks when low doses of a high-LET radiation are
protracted in time. The formal features of the model are
kinetics in the absence of repair. Generally, the model would
not be applicable to tumour induction by sparsely ionising
radiations because of repair. However, even for tumours
induced by X-rays, when the conditions are right the yield of
tumours can be significantly increased because of compensa-
tory repopulation. Kaplan and Brown (1952) induced
lymphoid tumours in mice with single or multiple doses of
X-rays. Fractionating a given dose with two or four daily
fractions reduced the yield of tumours. From the work of Till
and McCulloch (1963) it is known that more marrow stem
cells survive daily fractionated doses because of the repair of
sublethal damage. Hence, one may infer from the net
reduction in tumorigenesis observed by Kaplan and Brown
(1952) that the repair of subeffective tumorigenic damage
outweighed the increase in tumorigenesis that would have
been expected from the increase in the survival of tumour-
susceptible cells due to the daily fractionation. Kaplan and
Brown also compared the yield of lymphoid tumours when
the interval between each of four fractions was increased to 4,
8 and 16 days. Increasing the interval from 1 to 4 days
caused an increase in tumour yield from 33% to 75%. At an
interval of 16 days the yield had returned to about the same
level as for 1 day intervals. Till and McCulloch (1964) also
showed that after a 1 day delay, within the next few days the
compensatory repopulation of surviving marrow stem cells
occurred. Repopulation implies that in the process target cells
would have occupied the transformation-sensitive window in
increasing numbers. Till and McCulloch also showed that
after the repopulation the stem-cell number returned to the
steady-state level. From this observation it would follow that
the steady-state level of cell number in the sensitive window
would have been re-established. These data indicate that, in
spite of repair competence of the target cells for lymphoid
tumour induction, a large increase in the X-ray yield of
tumours was possible because of kinetics, which significantly
increased the numbers of cells in the sensitive window at each
successive dose fraction (see Elkind, 1993, for a further
discussion of these data).
Protracted low-LET radiation and breast cancer
People in general and women in particular have been exposed
mainly to sparsely ionising radiation like X-rays and mainly
for medical purposes. Although fractionated radiation
exposures have been shown to induce breast cancer (e.g.
Shore et al., 1986; Hoffman et al., 1989; Hrubec et al., 1989;
Boice et al., 1991), a connection between induction and
competence to repair damage due to sparsely ionising
radiation was first proposed by Swift et al. (1991). They
estimated elevated cancer risks in ataxia telangiectasia (AT)
heterozygotes compared with non-carriers of the AT gene to
be 3-4 for all types of cancer and 5.1 for breast cancer,
presumably due to radiation exposure in the latter instance.
In two other studies elevated incidences of breast cancer were
found among AT heterozygotes, although an association with
radiation exposure was not made (Pippard et al., 1988;
Borresen et al., 1990). Based on radiation cell killing in vitro a
clear difference between cells from AT heterozygotes and
those from normal individuals has not always been readily
evident probably because of an overlap in the ranges of
response involved (Nagasawa et al., 1987). However,
chromosomal structural hypersensitivity of cells from AT
heterozygotes irradiated in G2 phase has been demonstrated,
presumably because such cells are deficient in the repair of
DNA damage (Parshad et al., 1985; Shiloh et al., 1989;
Sanford et al., 1990).
Whether induced by single whole-body exposures
(Tokunaga et al., 1987) or multiple-dose fractions to the
chest (Hrubec et al., 1989), breast cancer has been
characterised by long latencies (Boice et al., 1991).
Fractionated low-dose exposures were similar or as effective
as single exposures (Boice et al., 1991). In the case of lung
cancer, however, Howe (1995) concluded that no excess risk
was detectable from fractionated X-ray exposures. In contrast
to the target cells in lung cancer, the lack of a reduction of
the incidence of breast cancer with dose fractionation
suggests that in this case the target cells were repair
deficient. This inference is supported by a study in which
the repair competencies of lymphocytes from AT hetero-
zygotes and from sporadic breast cancer patients were
compared with those from normal controls (Scott et al.,
1994). Using measurements of structural chromosome
damage when cells were irradiated in G2 they found that
lymphocytes from breast cancer patients, tested before
therapy, yielded a broad distribution of aberrations, that
overlapped the distributions of controls at one extreme and
AT heterozygotes at the other. Nine per cent of the controls
overlapped the range of aberrations observed with cells from
AT heterozygotes whereas 42% of the cells from breast
cancer patients had a similar overlap. Given that the estimate
of AT heterozygotes in the general population is about 1%
(e.g. Swift et al., 1991), their results indicate that a sizeable
fraction of cells from breast cancer patients were repair
deficient by the G2 irradiation test.
The preceding suggests that the target cells in a sizeable
fraction of woman who are susceptible to breast cancer
harbour a radiation repair deficiency. This suggestion satisfies
one of the requirements of the model in order for it to be
applicable to low-LET cancer risks. But what about the
requirement for kinetics? Invasive ductal carcinoma accounts
for about 75% of breast cancers (Fisher et al., 1975).
Between puberty and menopause the cyclic oestrogen and
progesterone secretions ensure that susceptible cells are
stimulated to divide, albeit in a cyclic manner. Hence, it is
quite likely that during the course of protracted exposure to
sparsely ionising radiation target cells will have had an
opportunity to progress into the sensitive window.
Although the connection is not known between repair
competence assayed by the G2 lymphocyte test and those
reparative processes that ordinarily reduce the induction of
transformation and breast cancer, it is a possibility that the
assay may underestimate the frequency of women who have
an enhanced susceptibility. The reason is that repair related
to target cell survival would also be involved. Enhanced cell
killing, because of deficient repair, could give rise to increased
compensatory repopulation and thus a greater flux of target
cells into the sensitive window as sketched in Figure 3.
Cancer incidence and protracted exposure to X- or y-rays
The radiobiological model that has been described-kinetics
in the absence of repair-is applicable to instances in which
doses of high-LET radiation are protracted. Protraction of
the exposure allows time for cells to progress into the
sensitive window, late G2/mitosis, during the normal
maintenance of tissue function and integrity, or whenProbacted expoue to X- or --rays mnd breas cancer
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induced to do so by compensatory mechanisms as well as by
ancillary stimuli from other chemical or physical effectors. As
for repair, in the instance of high-LET radiation a limited
role is assured because of the qualitative differences in the
intracellular damage from densely ionising particles com-
pared with that from low-LET radiation.
As noted, for the model to have applicability to protracted
exposure to low-LET radiation in addition to kinetics
deficient repair is required. The latter property results from
a characteristic of the cell and not the nature ofthe radiation
damage. When repair deficiency obtains a concomitant
requirement would be that the doses should be small. The
reason is that cells in the sensitive window constitute the
most sensitive moiety in the population and must survive the
exposure to express transformation. Repair deficiency relative
to transformation could be associated with a deficiency
relative to survival. Hence, to observe enhanced tumorigen-
esis with a low-LET radiation a balance between cell killing
and deficient repair would be required. In a given case the
balance might require doses so small that the magnitude of
the enhancement, resulting from kinetics during exposure,
might not be detectable.
Increased cell division has been invoked as a cause of
cancer because of the likelihood of molecular genetic errors
and the subsequent altered growth control of premalignant
and malignant cells (Preston-Martin et al., 1990). The model
described here is compatible with this possibility because even
for protracted exposures to y-rays, which can result in
reductions in the yield of somatic mutations, altered genetic
changes persist (Xing et al., 1995).
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